Fil LTD Bausch & Lomb Corp Transaction History

Fil LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$13.6 - $17.06 $20.7 Million - $26 Million	-1,525,705 Reduced 18.64%	6,659,495 $96.7 Million
Q1 2024 May 13, 2024	BUY	$13.68 - $17.6 $960,404 - $1.24 Million	70,205 Added 0.87%	8,185,200 $142 Million
Q4 2023 Feb 13, 2024	BUY	$14.87 - $17.56 $12.7 Million - $15 Million	855,250 Added 11.78%	8,114,995 $138 Million
Q3 2023 Nov 13, 2023	BUY	$16.8 - $20.99 $12 Million - $15 Million	716,448 Added 10.95%	7,259,745 $123 Million
Q2 2023 Aug 11, 2023	BUY	$16.03 - $20.07 $59.6 Million - $74.6 Million	3,719,213 Added 131.7%	6,543,297 $131 Million
Q1 2023 May 11, 2023	SELL	$15.67 - $18.91 $12.5 Million - $15.1 Million	-800,000 Reduced 22.07%	2,824,084 $49.2 Million
Q4 2022 Feb 13, 2023	BUY	$13.5 - $17.14 $8,815 - $11,192	653 Added 0.02%	3,624,084 $56.2 Million
Q3 2022 Nov 10, 2022	BUY	$14.23 - $17.76 $51.6 Million - $64.4 Million	3,623,431 New	3,623,431 $55.6 Million

118

37.8M

116K

299K

Ticker BLCO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 350,000,000
Market Cap $6.3B
Description
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.